NO873854L - Fremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse. - Google Patents

Fremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse.

Info

Publication number
NO873854L
NO873854L NO87873854A NO873854A NO873854L NO 873854 L NO873854 L NO 873854L NO 87873854 A NO87873854 A NO 87873854A NO 873854 A NO873854 A NO 873854A NO 873854 L NO873854 L NO 873854L
Authority
NO
Norway
Prior art keywords
preparing
procedure
therapeutic active
active relationship
relationship
Prior art date
Application number
NO87873854A
Other languages
English (en)
Other versions
NO873854D0 (no
NO171411B (no
NO171411C (no
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO873854D0 publication Critical patent/NO873854D0/no
Publication of NO873854L publication Critical patent/NO873854L/no
Publication of NO171411B publication Critical patent/NO171411B/no
Publication of NO171411C publication Critical patent/NO171411C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/322,3-Dihydro derivatives, e.g. flavanones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO87873854A 1986-01-17 1987-09-15 Analogifremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse NO171411C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/000091 WO1987004344A1 (en) 1986-01-17 1986-01-17 Hydroxyacetic acid derivatives for the treatment of diabetic complications

Publications (4)

Publication Number Publication Date
NO873854D0 NO873854D0 (no) 1987-09-15
NO873854L true NO873854L (no) 1987-09-15
NO171411B NO171411B (no) 1992-11-30
NO171411C NO171411C (no) 1993-03-10

Family

ID=22195340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO87873854A NO171411C (no) 1986-01-17 1987-09-15 Analogifremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse

Country Status (26)

Country Link
US (1) US4853410A (no)
EP (1) EP0230379B1 (no)
JP (1) JPS62169775A (no)
KR (1) KR890004104B1 (no)
CN (1) CN1015545B (no)
AT (1) ATE62237T1 (no)
AU (1) AU574001B2 (no)
CA (1) CA1283119C (no)
DD (1) DD266735A5 (no)
DE (1) DE3768966D1 (no)
DK (1) DK21687A (no)
EG (1) EG18353A (no)
ES (1) ES2022319B3 (no)
FI (1) FI94636C (no)
GR (1) GR3001863T3 (no)
HU (1) HU206618B (no)
IE (1) IE59450B1 (no)
IL (1) IL81261A (no)
NO (1) NO171411C (no)
NZ (1) NZ218970A (no)
PH (2) PH22231A (no)
PL (1) PL148082B1 (no)
PT (1) PT84107B (no)
WO (1) WO1987004344A1 (no)
YU (1) YU46042B (no)
ZA (1) ZA87309B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
WO1999043315A1 (fr) * 1998-02-25 1999-09-02 Shionogi & Co., Ltd. Agent therapeutique utilisable en cas de complication de diabetes
AT502844B1 (de) * 2005-12-12 2007-08-15 Fronius Int Gmbh Schweissbrenner und endstück sowie kontaktrohr für einen schweissbrenner
CN102171200B (zh) * 2008-10-02 2015-09-30 坎布雷卡尔斯库加公司 用于制备二酮类和药物的方法
CN105924425B (zh) * 2016-04-29 2018-06-05 浙江师范大学 一种制备二氢硫色满衍生物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359161A (en) * 1963-08-29 1967-12-19 Kefalas As Thiaxanthenols, process of producing and anti-tussive compositions thereof
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4210663A (en) * 1978-11-08 1980-07-01 Pfizer Inc. Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
ATE11781T1 (de) * 1981-05-13 1985-02-15 Imperial Chemical Industries Plc Pharmazeutische zubereitungen, die spirosuccinimidderivate enthalten.
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds

Also Published As

Publication number Publication date
EP0230379B1 (en) 1991-04-03
IL81261A (en) 1992-05-25
HUT48230A (en) 1989-05-29
EG18353A (en) 1993-02-28
NO873854D0 (no) 1987-09-15
DD266735A5 (de) 1989-04-12
YU5787A (en) 1988-04-30
DK21687D0 (da) 1987-01-16
FI94636B (fi) 1995-06-30
PT84107B (pt) 1989-07-31
PH24703A (en) 1990-10-01
EP0230379A2 (en) 1987-07-29
DE3768966D1 (de) 1991-05-08
ES2022319B3 (es) 1991-12-01
NO171411B (no) 1992-11-30
FI873843A0 (fi) 1987-09-04
PH22231A (en) 1988-07-01
FI94636C (fi) 1995-10-10
PL263678A1 (en) 1988-04-14
ZA87309B (no) 1988-07-18
HU206618B (en) 1992-12-28
AU6764187A (en) 1987-07-30
EP0230379A3 (en) 1988-10-05
PT84107A (en) 1987-02-01
CN87100191A (zh) 1987-09-09
CA1283119C (en) 1991-04-16
NZ218970A (en) 1988-11-29
NO171411C (no) 1993-03-10
US4853410A (en) 1989-08-01
ATE62237T1 (de) 1991-04-15
DK21687A (da) 1987-07-18
CN1015545B (zh) 1992-02-19
KR870007149A (ko) 1987-08-17
JPS62169775A (ja) 1987-07-25
FI873843A (fi) 1987-09-04
PL148082B1 (en) 1989-09-30
JPH0586952B2 (no) 1993-12-14
YU46042B (sh) 1992-12-21
IE59450B1 (en) 1994-02-23
IL81261A0 (en) 1987-08-31
IE870131L (en) 1987-07-17
GR3001863T3 (en) 1992-11-23
KR890004104B1 (ko) 1989-10-20
AU574001B2 (en) 1988-06-23
WO1987004344A1 (en) 1987-07-30

Similar Documents

Publication Publication Date Title
AU5303790A (en) Method of treating menial disorders
PT87542A (pt) Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
EP0350036A3 (en) Topical hematoporphyrin
FI95653C (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
NO873854L (no) Fremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse.
ZA893086B (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial disease
NO176477C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
ATE116849T1 (de) Pharmazeutische verwendung von fettsäuren.
NO167861C (no) Analogifremgangsmaate for fremstilling av en ny, terapeutisk aktiv indolokinolinforbindelse.
NO176099C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(2-okso-3-pyridyl)-kromanderivater
DK0566567T3 (da) Antihypertensive benzopyranderivater
NO872810D0 (no) Fremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse.
NO169717C (no) Fremgangsmaate for fremstilling av et stabilt hydrat av etpenicillinderivat.
ATE66811T1 (de) Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl>methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.